Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review DOI

Abdul Moeed,

Muhammad Omar Larik,

Muhammad Ahmed Ali Fahim

et al.

World Journal of Hepatology, Journal Year: 2024, Volume and Issue: 16(8), P. 1185 - 1198

Published: Aug. 22, 2024

Many studies have revealed a link between non-alcoholic fatty liver disease (NAFLD) and coronavirus 2019 (COVID-19), making understanding the relationship these two conditions an absolute requirement.

Language: Английский

Post-COVID-19 Pandemic Sequelae in Liver Diseases DOI Creative Commons
Cristina Stasi

Life, Journal Year: 2025, Volume and Issue: 15(3), P. 403 - 403

Published: March 4, 2025

During the coronavirus disease 2019 (COVID-19) pandemic, several studies highlighted a worse prognosis for patients with alterations in liver function tests, especially those pre-existing diseases. However, further are needed to define long-term impact of COVID-19 pandemic on Long encompasses wide range signs and symptoms, including exacerbations chronic conditions or new onset developed after acute phase. Therefore, effects extensively include hepatic manifestations. The co-expression angiotensin-converting receptor 2 (ACE2) transmembrane serine protease (TMPRSS2) has been demonstrated also enterocytes, cholangiocytes, hepatocytes. Studies post-COVID-19 sequelae have shown presence steatosis necroinflammation liver, concomitantly an alteration inflammation, cytolysis cholestasis indices. Some increased risk hepatobiliary pathologies, secondary biliary cholangitis worsening severity metabolic-associated fatty (MASLD). Based these premises, this review aims provide overview pathophysiological mechanisms contributing COVID-19-related damage; explore its implications inflammation fibrosis, particular focus MASLD metabolic dysfunction-associated steatohepatitis (MASH); analyze short- sequelae. A literature search was conducted using PubMed database relevant published English.

Language: Английский

Citations

0

Health in All Policies: Working Across Sectors in Cooperative Extension to Promote Health for All DOI Creative Commons

Michele Walsh,

Deborah H. John,

Nicole Peritore

et al.

Journal of Human Sciences and Extension, Journal Year: 2018, Volume and Issue: unknown

Published: May 14, 2018

A Health in All Policies approach engages cross-sector stakeholders to collaboratively improve systems that drive population health. We, the members of Extension Committee on Organization and Policy (ECOP)’s Action Team, propose adopting a within national Cooperative System will better prepare us contribute meaningfully improving nation’s We first explain argue for why how it is relevant Extension. then present insights gathered from Family Consumer Sciences program leaders state specialists assess whether leadership are poised adopt their affiliated programs. Although participant saw value contributing health improvement, they generally system as having lower levels readiness such an approach. Six themes emerged ways increase Extension’s engagement Policies: paradigm shift Extension, professional development competencies, transformational support, continued new partnerships, information access all disciplines

Language: Английский

Citations

7

Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review DOI

Abdul Moeed,

Muhammad Omar Larik,

Muhammad Ahmed Ali Fahim

et al.

World Journal of Hepatology, Journal Year: 2024, Volume and Issue: 16(8), P. 1185 - 1198

Published: Aug. 22, 2024

Many studies have revealed a link between non-alcoholic fatty liver disease (NAFLD) and coronavirus 2019 (COVID-19), making understanding the relationship these two conditions an absolute requirement.

Language: Английский

Citations

0